Livanova News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

03.07.18	LivaNova to Host Conference Call for Second Quarter 2018 Results (Businesswire)
14.06.18	LivaNova Receives FDA Clearance and Completes First Implant for its MEMO 4D Semi-rigid Mitral Annuloplasty Ring (Businesswire)
13.06.18	LivaNova Welcomes William Kozy to Board of Directors (Businesswire)
11.06.18	LivaNova’s Perceval Sutureless Aortic Heart Valve Approved in Japan (Businesswire)
01.06.18	NASH Data Drives MDGL To The Moon, VKTX Turns Head, FDA Nod For KTOV (RTTNews)
31.05.18	LivaNova to Present at the Jefferies and Goldman Sachs Conferences (Businesswire)
30.05.18	LivaNova Comments on the U.S. Centers for Medicare & Medicaid Services’ Reconsideration of its National Coverage Determination for VNS Therapy for Treatment-Resistant Depression (Businesswire)
02.05.18	LivaNova Reports First Quarter 2018 Results (Businesswire)
30.04.18	LivaNova schliesst Verkauf des Geschäftsbereichs Herzrhythmusmanagement an MicroPort Scientific Corporation ab (Businesswire)
30.04.18	LivaNova Completes Sale of Cardiac Rhythm Management Business to MicroPort Scientific Corporation (Businesswire)
26.04.18	LivaNova Announces One-Millionth Inspire Adult Oxygenator Patient (Businesswire)
18.04.18	LivaNova erhält CE-Kennzeichnung für VNS Therapy SenTiva-Generator und zukunftsweisendes Programmiersystem zur Behandlung von Epilepsie (Businesswire)
17.04.18	LivaNova Receives CE Mark for VNS Therapy SenTiva Generator and Next-Generation Programming System for Treatment of Epilepsy (Businesswire)
05.04.18	LivaNova to Host Conference Call for First Quarter 2018 Results (Businesswire)
04.04.18	LivaNova Completes Acquisition of TandemLife (Businesswire)
30.03.18	Bicarbon-Aortenklappen von LivaNova erhalten CE-Kennzeichnung für die erweiterte Anwendung mit niedriger dosierten Blutverdünnungsmitteln bei Patienten mit niedrigem Risiko (Businesswire)
29.03.18	LivaNova Bicarbon Aortic Valves Receive CE Mark for Expanded Use Labeling with Lower-Dose Blood Thinners in Low-Risk Patients (Businesswire)
28.03.18	LivaNova Commences Clinical Study to Evaluate Treatment Outcomes for Novel Microburst VNS Therapy System (Businesswire)
22.03.18	LivaNova Announces Enrollment for PERFECT Perceval Valve Clinical Trial in China (Businesswire)
08.03.18	LivaNova schliesst endgültige Vereinbarung über die Veräusserung seines Franchisegeschäfts Cardiac Rhythm Management an MicroPort Scientific Corporation ab (Businesswire)
08.03.18	LivaNova Enters into Definitive Agreement to Divest Its Cardiac Rhythm Management Business Franchise to MicroPort Scientific Corporation (Businesswire)
15.02.18	LivaNova übernimmt TandemLife (Businesswire)
15.02.18	LivaNova to Present at the Barclays and Cowen Conferences (Businesswire)
14.02.18	LivaNova to Acquire TandemLife (Businesswire)
01.02.18	LivaNova Announces CE Mark for PureFlex Arterial Cannulae Line for Conventional Cardiac Surgery (Businesswire)
24.01.18	LivaNova to Host Conference Call for Fourth Quarter and Full-Year 2017 Results (Businesswire)
11.01.18	LivaNova Initiates BELIEVE Aortic Heart Valve Study in the U.S. and Canada (Businesswire)
08.01.18	LivaNova Announces Matthew J. Dodds as Senior Vice President, Corporate Development (Businesswire)
04.01.18	LivaNova Commences Global RESTORE-LIFE Study for Treatment-Resistant Depression (Businesswire)
06.12.17	LivaNova steht vor Übernahme von ImThera Medical, Inc. (Businesswire)
05.12.17	LivaNova to Acquire ImThera Medical, Inc. (Businesswire)
21.11.17	LivaNova schliesst bindenden Vorvertrag für Verkauf seines Franchisegeschäfts für Herzrhythmusmanagement an MicroPort Scientific Corporation für 190 Millionen USD ab (Businesswire)
20.11.17	LivaNova To Sell CRM Business Franchise For $190 Mln; Updates FY17 Outlook (RTTNews)
20.11.17	LivaNova Enters into Binding Letter of Intent to Sell its Cardiac Rhythm Management Business Franchise to MicroPort Scientific Corporation for $190 Million (Businesswire)
07.11.17	LivaNova to Present at the Piper Jaffray and Berenberg Conferences (Businesswire)
01.11.17	LivaNova Recognizes Epilepsy Awareness Month This November (Businesswire)
02.10.17	LivaNova Announces One-Millionth Patient Treated with Advanced XTRA Autotransfusion System (Businesswire)
28.09.17	LivaNova to Host Conference Call for Third Quarter 2017 Results (Businesswire)
27.09.17	LivaNova and MicroPort Announce the Approval of Rega Pacemakers by the China Food and Drug Administration (Businesswire)
25.09.17	LivaNova Announces U.S. Launch of Optiflow Arterial Cannulae Family (Businesswire)
15.09.17	LivaNova will strategische Optionen für Franchisegeschäft Cardiac Rhythm Management untersuchen (Businesswire)
14.09.17	LivaNova Defines Strategic Outlook at Investor Day (Businesswire)
14.09.17	LivaNova to Explore Strategic Options for Cardiac Rhythm Management Business Franchise (Businesswire)
11.09.17	LivaNova Announces Publication of Literature Review Highlighting the Clinical Value and Safety of the Perceval Sutureless Valve for Aortic Valve Replacement (Businesswire)
31.08.17	LivaNova to Host Audio Webcast of Inaugural Investor Day (Businesswire)
07.08.17	LivaNova Implements 3T Heater-Cooler Device Modification (Businesswire)
07.08.17	LivaNova führt Modifikation an 3T Hypothermiegerät ein (Businesswire)
04.08.17	LivaNova’s Perceval Sutureless Aortic Heart Valve Awarded New Technology Add-on Payment from the Center for Medicare and Medicaid Services (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	302.80	1.30 %	K V
Alcon	76.88	0.65 %	K V
Sika	218.00	0.37 %	K V
Kuehne+Nagel Int	202.60	-0.20 %	K V
Logitech Intl	78.28	-0.33 %	K V
ABB	49.25	-1.44 %	K V
Holcim	87.68	-1.55 %	K V
Zurich Insur Gr	531.20	-1.63 %	K V
Roche Hldg G	267.20	-1.69 %	K V
UBS Group	29.78	-1.94 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Livanova PLC

Aktien Top/Flop

Livanova Peer Group Nachrichten

Meistgelesene Nachrichten